47
Views
6
CrossRef citations to date
0
Altmetric
Case Report

Rapidly progressive stage IVB mycosis fungoides treated with low-dose total skin electron beam therapy

, , , &
Pages 1597-1601 | Published online: 01 Jul 2015

References

  • BartonPTDevesaSSAndersonWFToroJRCutaneous lymphoma incidence in the United States: a population based study of 3,884 casesBlood20091135064507319279331
  • Alberti-ViolettiSRalpurRSchlichteMSuiDDuvicMAdvanced-stage mycosis fungoides and Sezary syndrome: survival and response to treatmentClin Lymphoma Myeloma Leuk2015156e105e11225817937
  • DemierreMFGanSJonesJMillerDRSignificant impact of cutaneous T-cell lymphoma on patients’ quality of life: results of a 2005 National Cutaneous Lymphoma Foundation SurveyCancer200610710250417048251
  • HindsGAAlhaririJKleinRQWilsonLDTreatment of mycosis fungoides with total skin electron beam. Response and relapse by ethnicity and sexAm J Clin Oncol201336548148522706179
  • OlsenEVonderheidEPimpinelliNISCL/EORTCRevisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphoma (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)Blood20071101713172217540844
  • JonesGWKacinskiBMWilsonLDTotal skin electron radiation in the management of mycosis fungoides: consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project GroupJ Am Acad Dermatol20024736437012196745
  • MazzeoERubinoLBuglioneMThe current management of mycosis fungoides and Sezary syndrome and the role of radiotherapy: principles and indicationsRep Pract Oncol Radiother201419779124936325
  • TrautingerFKnoblerRWillemzeREORTC consenus recommendations for the treatment of mycosis fungoides/Sezary syndromeEur J Cancer2006421014103016574401
  • PiotrowskiTMileckiPSkorskaMFundowiczDTotal skin electron irradiation techniques: a reviewPostepy Dermaol Alergol20133015055
  • OlsenEAWhittakerSKimYHInternational Society for Cutaneous LymphomasUnited States Cutaneous Lymphoma ConsortiumCutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of CancerClinical end points and response criteria in mycosis fungoides and sezary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of CancerJ Clin Oncol201129182598260721576639
  • TalpurRSinghLDaulatSLong-term outcomes of 1,236 patients with mycosis fungoides and Sézary syndrome from 1982 to 2009Clin Cancer Res2012185051506022850569
  • ScarisbrickJJKimYHWhittakerSJPrognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?Br J Dermatol20141701226123624641480
  • SmithBDWilsonLDManagement of mycosis fungoides. Treatment: part 2Oncology2003171419142814606365
  • NCCNClinical Practice Guideline in Oncology: Non-Hodgkin’s Lymphomas, Version 42014 Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines.aspAccessed April 9, 2015
  • NaviDRiazNLevinYSSullivanNCKimYHHoppeRTThe Stanford University experience with conventional-dose, total skin elecron-beam therapy in the treatment of generalized patch or plaque (T2) and tumor (T3) mycosis fungoidesArch Dermatol2011147556156721576575
  • SpechtLDabajaBIllidgeTWilsonLDHoppeRTInternational Lymphoma Radiation Oncology GroupModern radiation therapy for primary cutaneous lymphomas: field and dose guidelines from the international lymphoma radiation oncology groupInt J Radiat Oncol Biol Phys2015921323925863751
  • HarrisonCYoungJNaviDRevisiting low-dose total skin electron beam therapy in mycosis fungoidesInt J Radiat Oncol Biol Phys2011814e651e65721489711
  • HoppeRTHarrisonCTavallaeeMLow-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trialsJ Am Acad Dermatol201572228629225476993
  • KimYHLiuHLMraz-GernhardSVargheseAHoppeRTLong term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progressionArch Dermatol200313985786612873880